Rare Squamous Cell Carcinoma Case Report Unveiled

Strategic Insights -

Researchers at Nanjing University of Chinese Medicine have detailed a rare case of squamous cell carcinoma arising from recurrent anal fistula in a 66-year-old patient. The study highlights the complexities of diagnosing and treating this rare malignant transformation, often associated with chronic inflammation, reduced immune function, and prior abdominal surgery. The patient's unique case provides new insights into the clinical characteristics of anal fistula carcinogenesis.

Key Takeaways:

  • The patient had a history of recurrent anal fistula spanning more than 10 years, undergoing three surgical treatments before the diagnosis of squamous cell carcinoma.
  • Pathological findings from the first two surgeries showed no malignant lesions, while the third confirmed moderately to poorly differentiated squamous cell carcinoma.
  • Carcinoembryonic antigen and cytokeratin 19 fragment levels were mildly elevated, and imaging revealed a high complex anal fistula.
  • The diagnosis was ultimately confirmed by pathological biopsy, highlighting the importance of pathological confirmation in diagnosing this rare condition.
  • The patient had a history of lymphoma and small bowel resection, and HIV infection was excluded upon admission.
  • The study suggests that malignant transformation may be linked to chronic inflammatory stimulation, reduced immune function, and prior abdominal surgery, providing a new perspective on the clinical characteristics of anal fistula carcinogenesis.

Statistics:

  • The patient was 66 years old at the time of diagnosis.
  • The patient had a history of recurrent anal fistula spanning more than 10 years.
  • The patient underwent three surgical treatments before the diagnosis of squamous cell carcinoma.
  • Carcinoembryonic antigen levels were mildly elevated at 5.8 ng/mL.
  • Cytokeratin 19 fragment levels were mildly elevated at 10.2 ng/mL.
  • Imaging revealed a high complex anal fistula.

Sources:

  • Case report of squamous cell carcinoma secondary to recurrent anal fistula. Frontiers in Oncology, 2025,15.
  • NewsRx. Nanjing University of Chinese Medicine Researchers Add New Data to Research in Squamous Cell Carcinoma (Case report of squamous cell carcinoma secondary to recurrent anal fistula). AIDS Weekly. October 20, 2025; p 86.